TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+3.73%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$3.11B
AUM Growth
+$3.11B
(+0.92%)
Cap. Flow
+$26.2M
Cap. Flow
% of AUM
0.84%
Top 10 Holdings %
Top 10 Hldgs %
33.83%
Holding
206
New
17
Increased
43
Reduced
39
Closed
34
Top Buys
| 1 |
Rallybio
RLYB
|
$37.6M |
| 2 |
Guardant Health
GH
|
$28.7M |
| 3 |
Idexx Laboratories
IDXX
|
$27.9M |
| 4 |
Amgen
AMGN
|
$23.7M |
| 5 |
AstraZeneca
AZN
|
$21.9M |
Top Sells
| 1 |
Elevance Health
ELV
|
$34.7M |
| 2 |
ResMed
RMD
|
$32.6M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$22.2M |
| 4 |
DexCom
DXCM
|
$21.8M |
| 5 |
Ascendis Pharma
ASND
|
$13.7M |
Sector Composition
| 1 | Healthcare | 96.51% |
| 2 | Real Estate | 2.72% |
| 3 | Industrials | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Novo Nordisk
NVO
$252B
| $9.19M | 0.3% |
95,703
+47,297
| +98% | +$4.54M |
|
77
Omega Healthcare
OHI
$12.5B
| $9.18M | 0.3% |
306,433
| – | – |
|
78
Mettler-Toledo International
MTD
$26.1B
| $9.16M | 0.29% |
6,650
-3,150
| -32% | -$4.34M |
|
|
DOC
79
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $8.74M | 0.28% |
495,733
| – | – |
|
|
GTHX
80
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $8.38M | 0.27% |
624,369
| – | – |
|
81
Universal Health Services
UHS
$11.6B
| $8.31M | 0.27% |
60,023
| – | – |
|
82
Medical Properties Trust
MPW
$2.66B
| $8.26M | 0.27% |
411,743
| – | – |
|
83
Boston Scientific
BSX
$159B
| $8.07M | 0.26% |
185,931
| – | – |
|
|
TPTX
84
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $7.93M | 0.26% |
119,324
| – | – |
|
85
Intellia Therapeutics
NTLA
$1.26B
| $7.81M | 0.25% |
58,180
| – | – |
|
86
uniQure
QURE
$954M
| $7.59M | 0.24% |
237,008
+11,087
| +5% | +$355K |
|
87
Sutro Biopharma
STRO
$85.6M
| $7.56M | 0.24% |
400,147
| – | – |
|
88
Sabra Healthcare REIT
SBRA
$4.56B
| $7.52M | 0.24% |
510,660
| – | – |
|
89
Sanofi
SNY
$122B
| $7.39M | 0.24% |
153,254
+71,700
| +88% | +$3.46M |
|
90
Philips
PHG
$25.8B
| $7.32M | 0.24% |
164,790
+107,863
| +189% | +$4.79M |
|
|
GRTX
91
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $7.28M | 0.23% |
898,374
-143,471
| -14% | -$1.16M |
|
92
Arvinas
ARVN
$580M
| $7.07M | 0.23% |
85,997
| – | – |
|
93
Addus HomeCare
ADUS
$2.08B
| $6.67M | 0.21% |
83,632
+29,395
| +54% | +$2.34M |
|
94
Apellis Pharmaceuticals
APLS
$3.51B
| $6.45M | 0.21% |
195,820
+43,282
| +28% | +$1.43M |
|
95
Agilent Technologies
A
$35.5B
| $6.24M | 0.2% |
39,625
-12,900
| -25% | -$2.03M |
|
96
Smith & Nephew
SNN
$16.2B
| $6.24M | 0.2% |
181,710
+74,040
| +69% | +$2.54M |
|
97
Teva Pharmaceuticals
TEVA
$21.5B
| $5.92M | 0.19% |
607,651
| – | – |
|
98
Revvity
RVTY
$9.68B
| $5.8M | 0.19% |
33,444
-3,650
| -10% | -$633K |
|
|
LTC
99
LTC Properties
LTC
$1.67B
| $5.78M | 0.19% |
182,293
| – | – |
|
100
Amicus Therapeutics
FOLD
$2.42B
| $5.61M | 0.18% |
587,277
-34,382
| -6% | -$328K |
|